One of the more recent areas of exploration in drug design is the fragment-based drug design, (FBDD) where most-active scaffolds or moieties of active drug compounds can be used in designing drug compounds with synergistic-like effects in terms of activity, and physicochemical properties such as reduced or less toxic effects is a process called Molecular Hybridization . To combat this disease, new antimalarial agents with novel biological targets are required.